April 7 (Reuters) - Chinook Therapeutics Inc KDNY.O :
* CHINOOK THERAPEUTICS PROVIDES BUSINESS UPDATE AND REPORTS
FOURTH
QUARTER AND FULL YEAR 2020 FINANCIAL RESULTS
* Q4 LOSS PER SHARE $1.24
* Q4 EARNINGS PER SHARE ESTIMATE $-0.41 -- REFINITIV IBES
DATA
* CHINOOK THERAPEUTICS - CASH, CASH EQUIVALENTS AND
MARKETABLE
SECURITIES TOTALED $250.4 MILLION AT DECEMBER 31, 2020
* CHINOOK THERAPEUTICS - EXPECT CASH POSITION TO FUND
OPERATIONS
TO MIDDLE OF 2023
Source text for Eikon: ID:nGNXbcfspw
Further company coverage: KDNY.O
((Reuters.Briefs@thomsonreuters.com;))